Industry ownership intelligence

Medical Devices insider conviction

Executive and director activity assessed across 82 companies for breadth, transaction quality, clustering, freshness, and directional conviction.

Market dashboard Healthcare sector Company signals Filing ledger Data API

47/100

Balanced insider tape

90/100 confidence

Level: Industry
Evidence window: Latest 90 days
Named insiders: 656
Latest evidence: 7 Aug 2026

Capital positioning read

Balanced insider tape

Acquisition and disposal evidence is mixed after low-information compensation and derivative activity is separated out.

Wait for clearer clustering

Evidence in favour

135 distinct acquisition events survive duplicate and security-type controls.
Participation spans 656 named insiders rather than one filing source.
The latest qualifying evidence is fresh, dated 07 Aug 2026.

Decision risks

Qualifying disposal events outnumber acquisitions, although disposals receive a lower directional weight.

Conviction47Balanced insider tape

Confidence90Deep evidence

Controlled events548directional common-share events

Company breadth82represented companies

Acquisition value$28.9Mnormalized amount

Disposal value$275.6Mnormalized amount

Flow regime

Twelve-week filing pressure

Shows the cadence and balance of the full filing tape.

15825 May

30901 Jun

16008 Jun

15715 Jun

7922 Jun

11129 Jun

7006 Jul

4213 Jul

3120 Jul

8227 Jul

5303 Aug

010 Aug

AcquisitionsDisposalsScore 47 · Confidence 90

Relative positioning

Industry peer map

Current score with confidence.

Pharmaceutical RetailersConviction accumulation7216 confidence Medical DistributionConviction accumulation6874 confidence Drug Manufacturers - GeneralBalanced insider tape5694 confidence BiotechnologyBalanced insider tape5391 confidence Medical DevicesBalanced insider tape4790 confidence Diagnostics & ResearchDistribution bias3894 confidence Medical Care FacilitiesDistribution bias3793 confidence Medical Instruments & SuppliesDistribution bias3791 confidence Healthcare PlansDistribution bias3692 confidence Health Information ServicesDistribution bias3691 confidence Drug Manufacturers - Specialty & GenericDistribution bias3594 confidence

Directional balance

Controlled event mix

24.6%acquisition

Acquisition events: 135
Disposal events: 413
Net value: -$246.7M

Accumulation

Constructive company clusters

RCELAvita Medical Ltd8868 conf.BSXBoston Scientific Corp8696 conf.TMCITreace Medical Concepts Inc8672 conf.ENOVEnovis Corp8364 conf.RPIDRapid Micro Biosystems Inc8061 conf.CTSOCytosorbents Crp7840 conf.STIMNeuronetics Inc7552 conf.TELATela Bio Inc7551 conf.

Distribution review

Disposal concentrations

CTKBCytek Biosciences Inc1270 conf.IRMDIradimed Co1272 conf.LUNGPulmonx Corp1277 conf.AVNSAvanos Medical Inc1282 conf.MDTMedtronic PLC1289 conf.MASS908 Devices Inc1291 conf.DXCMDexCom Inc1294 conf.BFLYButterfly Network Inc1297 conf.

Evidence density

Most active controlled tapes

STE29 controlled events27Concentrated distribution TNDM25 controlled events36Distribution bias BFLY24 controlled events12Concentrated distribution QTRX23 controlled events29Concentrated distribution SIBN20 controlled events34Distribution bias CTKB19 controlled events12Concentrated distribution EW18 controlled events43Distribution bias IRMD17 controlled events12Concentrated distribution

Evidence quality

What the filings represent

Common equity1127

Equity compensation332

Options and derivatives238

Other securities10

Decision makers

Role participation

Director893

Other executive332

CEO and chair165

Finance leadership139

Other or unspecified124

Large holder54

Quality controls

Evidence usability

Normalized values: 35%
Priced common share: 34%
Named insiders: 656
Controlled events: 548

Auditable evidence

Latest Medical Devices filings

Showing 781 to 810 of 1707.

8 Jun 2026

PRCTProcept Biorobotics Corp

TEMPLIN, BARRY LEVP, Chief Technology Officer

DisposalCommon equity

$10.2KDirectional evidence

8 Jun 2026

PRCTProcept Biorobotics Corp

WATERS, KEVINEVP, CFO

DisposalCommon equity

$10.2KDirectional evidence

8 Jun 2026

PRCTProcept Biorobotics Corp

NOURI, ALALEHEVP, CLO, CORP. SEC.

DisposalCommon equity

$8.1KDirectional evidence

8 Jun 2026

SERASera Prognostics Inc

LAWRENCE, SANDRA AJDirector

DisposalCommon equity

$3.4KDirectional evidence

8 Jun 2026

IRIXIRIDEX Corporation

DIZON, ROMEO RChief Financial Officer

AcquisitionCommon equity

$2.7KDirectional evidence

6 Jun 2026

QDELQuidel Corporation

BUECHLER, KENNETH FDirector

DisposalEquity compensation